Daniel Triviño is a recognized industry expert with extensive experience in manufacturing execution systems (MES) and process optimization in the life sciences sector. With a rich history of presentations at prestigious conferences, including the 11th International Life Sciences Symposium in France and multiple CBI and IVT forums. Daniel has shared his expertise on integrating MES with ERP, enhancing floor performance, and implementing cutting-edge technologies. He recently presented on preparing sites for MES recipe deployment at Pharma MES USA 2023. His insights and practical knowledge have made significant contributions to the field, establishing him as a thought leader in manufacturing efficiency and innovation.

Takeda is a world-leading, value-driven, research-based biopharmaceutical company headquartered in Japan. Takeda's mission is to develop, manufacture and supply life-enhancing and life-sustaining medicines for the treatment of rare and complex diseases. Takeda seeks to improve people's lives by bringing to market new and better medicines that help to address the nation's most pressing healthcare needs. Their focus is on the areas of oncology, gastroenterology and diabetes.